Cargando…
ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression
Recent studies have shown that ANXA2 is important in the development of many cancers, while its role in glioma-related immune response remains unclear. We aimed to comprehensively investigate its biological characteristics and clinical value in glioma. We analyzed 699 glioma samples from The Cancer...
Autores principales: | Ma, Kaiming, Chen, Xin, Liu, Weihai, Yang, Yang, Chen, Suhua, Sun, Jianjun, Ma, Changcheng, Wang, Tao, Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531374/ https://www.ncbi.nlm.nih.gov/pubmed/34675316 http://dx.doi.org/10.1038/s41598-021-00366-8 |
Ejemplares similares
-
PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis
por: Ma, Kaiming, et al.
Publicado: (2022) -
CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas
por: Ma, Kaiming, et al.
Publicado: (2022) -
CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance
por: Ma, Kaiming, et al.
Publicado: (2022) -
PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021) -
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation
por: Lin, Zhongxiao, et al.
Publicado: (2021)